vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and HA Sustainable Infrastructure Capital, Inc. (HASI). Click either name above to swap in a different company.

CORCEPT THERAPEUTICS INC is the larger business by last-quarter revenue ($202.1M vs $114.8M, roughly 1.8× HA Sustainable Infrastructure Capital, Inc.). CORCEPT THERAPEUTICS INC runs the higher net margin — 12.0% vs -46.8%, a 58.8% gap on every dollar of revenue. On growth, HA Sustainable Infrastructure Capital, Inc. posted the faster year-over-year revenue change (13.3% vs 11.1%). Over the past eight quarters, CORCEPT THERAPEUTICS INC's revenue compounded faster (17.3% CAGR vs 4.2%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

HA Sustainable Infrastructure Capital, Inc. (HASI) is a specialized investment firm focused on sustainable infrastructure assets covering renewable energy, energy efficiency, sustainable real estate and low-carbon utility segments. It primarily operates in North American markets, providing long-term capital to eligible sustainable projects and delivering stable risk-adjusted returns to investors through recurring cash flows from operational underlying assets.

CORT vs HASI — Head-to-Head

Bigger by revenue
CORT
CORT
1.8× larger
CORT
$202.1M
$114.8M
HASI
Growing faster (revenue YoY)
HASI
HASI
+2.2% gap
HASI
13.3%
11.1%
CORT
Higher net margin
CORT
CORT
58.8% more per $
CORT
12.0%
-46.8%
HASI
Faster 2-yr revenue CAGR
CORT
CORT
Annualised
CORT
17.3%
4.2%
HASI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORT
CORT
HASI
HASI
Revenue
$202.1M
$114.8M
Net Profit
$24.3M
$-53.8M
Gross Margin
98.7%
Operating Margin
2.2%
-57.4%
Net Margin
12.0%
-46.8%
Revenue YoY
11.1%
13.3%
Net Profit YoY
-21.0%
-176.7%
EPS (diluted)
$0.20
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
HASI
HASI
Q4 25
$202.1M
$114.8M
Q3 25
$207.6M
$103.1M
Q2 25
$194.4M
$85.7M
Q1 25
$157.2M
$96.9M
Q4 24
$181.9M
$101.3M
Q3 24
$182.5M
$82.0M
Q2 24
$163.8M
$94.5M
Q1 24
$146.8M
$105.8M
Net Profit
CORT
CORT
HASI
HASI
Q4 25
$24.3M
$-53.8M
Q3 25
$19.7M
$83.3M
Q2 25
$35.1M
$98.4M
Q1 25
$20.5M
$56.6M
Q4 24
$30.7M
$70.1M
Q3 24
$47.2M
$-19.6M
Q2 24
$35.5M
$26.5M
Q1 24
$27.8M
$123.0M
Gross Margin
CORT
CORT
HASI
HASI
Q4 25
98.7%
Q3 25
97.8%
Q2 25
98.2%
Q1 25
98.5%
Q4 24
98.4%
Q3 24
98.4%
Q2 24
98.5%
Q1 24
98.3%
Operating Margin
CORT
CORT
HASI
HASI
Q4 25
2.2%
-57.4%
Q3 25
4.9%
Q2 25
13.7%
Q1 25
2.2%
84.7%
Q4 24
13.9%
90.9%
Q3 24
25.5%
-32.1%
Q2 24
21.7%
39.5%
Q1 24
20.1%
Net Margin
CORT
CORT
HASI
HASI
Q4 25
12.0%
-46.8%
Q3 25
9.5%
80.8%
Q2 25
18.1%
114.9%
Q1 25
13.1%
58.4%
Q4 24
16.9%
69.2%
Q3 24
25.9%
-23.9%
Q2 24
21.7%
28.1%
Q1 24
18.9%
116.3%
EPS (diluted)
CORT
CORT
HASI
HASI
Q4 25
$0.20
$-0.38
Q3 25
$0.16
$0.61
Q2 25
$0.29
$0.74
Q1 25
$0.17
$0.44
Q4 24
$0.25
$0.58
Q3 24
$0.41
$-0.17
Q2 24
$0.32
$0.23
Q1 24
$0.25
$0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
HASI
HASI
Cash + ST InvestmentsLiquidity on hand
$372.2M
$110.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$647.8M
$2.7B
Total Assets
$836.7M
$8.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
HASI
HASI
Q4 25
$372.2M
$110.2M
Q3 25
$421.7M
$301.8M
Q2 25
$342.2M
$86.5M
Q1 25
$322.8M
$67.4M
Q4 24
$383.3M
$129.8M
Q3 24
$380.3M
$44.1M
Q2 24
$473.2M
$145.7M
Q1 24
$410.8M
$61.4M
Stockholders' Equity
CORT
CORT
HASI
HASI
Q4 25
$647.8M
$2.7B
Q3 25
$631.9M
$2.7B
Q2 25
$635.8M
$2.6B
Q1 25
$683.3M
$2.5B
Q4 24
$679.6M
$2.4B
Q3 24
$638.8M
$2.3B
Q2 24
$596.2M
$2.3B
Q1 24
$547.9M
$2.3B
Total Assets
CORT
CORT
HASI
HASI
Q4 25
$836.7M
$8.2B
Q3 25
$823.6M
$8.2B
Q2 25
$801.7M
$7.6B
Q1 25
$846.5M
$7.5B
Q4 24
$840.6M
$7.1B
Q3 24
$784.3M
$6.7B
Q2 24
$714.6M
$6.7B
Q1 24
$655.9M
$6.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
HASI
HASI
Operating Cash FlowLast quarter
$38.4M
$167.3M
Free Cash FlowOCF − Capex
$38.4M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
HASI
HASI
Q4 25
$38.4M
$167.3M
Q3 25
$54.5M
$-121.8M
Q2 25
$43.9M
$79.6M
Q1 25
$5.1M
$-37.1M
Q4 24
$59.3M
$5.9M
Q3 24
$73.8M
$21.9M
Q2 24
$41.2M
$-24.8M
Q1 24
$23.8M
$20.9M
Free Cash Flow
CORT
CORT
HASI
HASI
Q4 25
$38.4M
Q3 25
Q2 25
$43.9M
Q1 25
$5.0M
Q4 24
$59.2M
Q3 24
$72.2M
Q2 24
$40.8M
Q1 24
FCF Margin
CORT
CORT
HASI
HASI
Q4 25
19.0%
Q3 25
Q2 25
22.6%
Q1 25
3.2%
Q4 24
32.5%
Q3 24
39.5%
Q2 24
24.9%
Q1 24
Capex Intensity
CORT
CORT
HASI
HASI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.9%
Q2 24
0.3%
Q1 24
0.0%
Cash Conversion
CORT
CORT
HASI
HASI
Q4 25
1.58×
Q3 25
2.77×
-1.46×
Q2 25
1.25×
0.81×
Q1 25
0.25×
-0.66×
Q4 24
1.93×
0.08×
Q3 24
1.56×
Q2 24
1.16×
-0.94×
Q1 24
0.86×
0.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons